Halogenated oxyquinoline derivatives and neurological syndromes.
D000005:Abdomen; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D007464:Clioquinol / Q000008:administration & dosage / Q000009:adverse effects*; D005243:Feces / Q000382:microbiology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009187:Myelitis / Q000139:chemically induced / Q000209:etiology*; D009900:Optic Nerve; D009902:Optic Neuritis / Q000139:chemically induced / Q000209:etiology*; D010146:Pain; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D013997:Time Factors; D014871:Water Microbiology; D014881:Water Supply
D007464:Clioquinol